A Case Report on Neonatal Bartter Syndrome and It’s Effective Management-Clinical Pharmacist Perspective
1, 1, 1, 1, 1, 1
- 1Department of Pharmacy Practice, Nandha College of Pharmacy, Erode, Tamilnadu, INDIA.
CORRESPONDENCE
Apollo James
Department of Pharmacy Practice, Nandha College of Pharmacy, Erode, Tamilnadu, INDIA.
Received: 06-07-2015; Accepted: 09-09-2015.
Volume 8, Issue 3 · pp. 133-135 · 2015 · DOI: 10.5530/ijopp.8.3.8
ABSTRACT
Bartter Syndrome is an inherited renal tubular disorder with hypokalaemia, hypochloremic and metabolic alkalosis. The syndrome was diagnosed by elevated serum renin levels, which is seen in our case, improved with potassium supplements and Indomethacin. In some patients Indomethacin therapy failed to resolve or prevent nephrocalcinosis. We are reporting a case of neonatal bartter syndrome responded well to Indomethacin and appropriate electrolyte therapy which gradually improved the general condition of the child. Unless there is a high degree of suspicion, patients may go undiagnosed or may be incorrectly managed for protein–energy malnutrition. Early diagnosis helps in improving the outcome by Angiotensin converting enzyme inhibitors (ACE) and NSAID’s.
KEYWORDS
REFERENCES
As publishedShowing references and in-text citations exactly as published.
Cite this article
SELECT FORMAT
Chaitanya, K., Jahnavi, C., Kiran, Y. K., James, A., Kumar, T. R. A., & Sivakumar, T. (2015). A Case Report on Neonatal Bartter Syndrome and It’s Effective Management-Clinical Pharmacist Perspective. Indian Journal of Pharmacy Practice, 8(3), 133-135. https://doi.org/10.5530/ijopp.8.3.8
Copyright and licence
© 2015 Author(s)
This is an open access article distributed under the terms of the Creative Commons Attribution 4.0 License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. CC BY 4.0